Cargando…

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor Progression

Currently, no treatments available for Parkinson’s disease (PD) can slow PD progression. At the early stage of the disease, only a subset of individuals with PD progress quickly, while the majority have a slowly progressive form of the disease. In developing treatments that aim to slow PD progressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Holly, Anzures-Cabrera, Judith, Taylor, Kirsten I., Pagano, Gennaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711238/ https://www.ncbi.nlm.nih.gov/pubmed/34966256 http://dx.doi.org/10.3389/fnins.2021.765765

Ejemplares similares

Changes in Cortical Thickness in Patients With Early Parkinson’s Disease at Different Hoehn and Yahr Stages
por: Gao, Yuyuan, et al.
Publicado: (2018)

Total Cerebral Small Vessel Score Association With Hoehn and Yahr Stage in Parkinson’s Disease
por: Ma, Xinxin, et al.
Publicado: (2021)

Time Taken for and Causes of a Decline to Hoehn and Yahr Stage 5 in Patients with Parkinson's Disease
por: Kashihara, Kenichi, et al.
Publicado: (2022)

Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson’s Disease Assessed by the Unified Parkinson’s Disease Rating Scale and the Hoehn–Yahr Stage
por: Shi, Chen, et al.
Publicado: (2016)

Differences in Home Health Nursing Care for Patients with Parkinson's Disease by Stage of Progress: Patients in Hoehn and Yahr Stages III, IV, and V
por: Iwasa, Yumi, et al.
Publicado: (2021)

Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage
por: Giladi, Nir, et al.
Publicado: (2016)

Identifying prodromal symptoms at high specificity for Parkinson’s disease
por: Jackson, Holly, et al.
Publicado: (2023)

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2014)

Negative DAT‐SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?
por: Palermo, Giovanni, et al.
Publicado: (2022)

The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2021)

Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2023)

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?
por: Okuzumi, A., et al.
Publicado: (2019)

The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease
por: Lorio, Sara, et al.
Publicado: (2019)

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An (123)I-FP-CIT SPECT study
por: Joling, Merijn, et al.
Publicado: (2019)

Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images
por: Rahmim, Arman, et al.
Publicado: (2017)

Assessment of different regions of interest-based methods for [99mTc]Tc DAT-SPECT quantification using an anthropomorphic striatal phantom
por: Alexandre-Santos, Leonardo, et al.
Publicado: (2022)

Fully Automated Quantification of the Striatal Uptake Ratio of [(99m)Tc]-TRODAT with SPECT Imaging: Evaluation of the Diagnostic Performance in Parkinson's Disease and the Temporal Regression of Striatal Tracer Uptake
por: Fang, Yu-Hua Dean, et al.
Publicado: (2015)

Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments
por: Rahmim, Arman, et al.
Publicado: (2016)

Prediction of Cognitive Decline in Parkinson’s Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems
por: Hosseinzadeh, Mahdi, et al.
Publicado: (2023)

Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake
por: Bae, Yun Jung, et al.
Publicado: (2023)

Striatal DAT availability does not change after supraphysiological glucose loading dose in humans
por: Pak, Kyoungjune, et al.
Publicado: (2021)

Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes
por: Shigekiyo, Taro, et al.
Publicado: (2020)

Multi-Atlas MRI-Based Striatum Segmentation for (123)I-FP-CIT SPECT (DAT-SPECT) Compared With the Bolt Method and SPECT-Atlas-Based Segmentation Method Toward the Accurate Diagnosis of Parkinson's Disease/Syndrome
por: Sohara, Koji, et al.
Publicado: (2021)

Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease
por: Trinh, Ilene, et al.
Publicado: (2023)

DAT genotype modulates striatal processing and long-term memory for items associated with reward and punishment()
por: Wittmann, Bianca C., et al.
Publicado: (2013)

Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study
por: Tsang, Kaki, et al.
Publicado: (2023)

Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice
por: Adriani, Walter, et al.
Publicado: (2012)

Interaction between striatal volume and DAT1 polymorphism predicts working memory development during adolescence
por: Nemmi, F., et al.
Publicado: (2018)

Extra-striatal Uptake of (99m)Tc-TRODAT SPECT in a Cerebral Meningioma: A Case Report
por: Sabour, Mahsa, et al.
Publicado: (2019)

Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: comparison of different volume of interest settings
por: Iwabuchi, Yu, et al.
Publicado: (2019)

Stereotactical normalization with multiple templates representative of normal and Parkinson-typical reduction of striatal uptake improves the discriminative power of automatic semi-quantitative analysis in dopamine transporter SPECT
por: Apostolova, Ivayla, et al.
Publicado: (2023)

Enlarged striatal volume in adults with ADHD carrying the 9-6 haplotype of the dopamine transporter gene DAT1
por: Onnink, A. Marten H., et al.
Publicado: (2016)

Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study
por: Menéndez-González, Manuel, et al.
Publicado: (2014)

Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
por: Shimizu, Soichiro, et al.
Publicado: (2015)

Local striatal volume and motor reserve in drug-naïve Parkinson’s disease
por: Jeong, Seong Ho, et al.
Publicado: (2022)

Intrasubject relationship between striatal (18)F-FP-CIT uptake and cardiac (123)I-MIBG uptake differs by motor subtype in early Parkinson disease
por: Jang, Wooyoung, et al.
Publicado: (2021)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
por: Harraz, Maged M.
Publicado: (2023)

Extra-striatal Uptake of (99m)Tc-TRODAT-1 in Meningioma Detected on SPECT/CT: Diagnostic Clue or Mere Coincidence?
por: Chandra, Piyush, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4satrkk7297h9v0sphs2bd4to0